Abstract
Singlet oxygen generated in a type II photodynamic action, due to its limited lifetime (1 μs) and reactive distance (<10 nm), could regulate live cell function nanoscopically. The genetically-encoded protein photosensitizers (engineered fluorescent proteins such as KillerRed, TagRFP, and flavin-binding proteins such as miniSOG, Pp2FbFPL30M) could be expressed in a cell type- and/or subcellular organelle-specific manner for targeted protein photo-oxidative activation/desensitization. The newly emerged active illumination technique provides an additional level of specificity. Typical examples of photodynamic activation include permanent activation of G protein-coupled receptor CCK1 and photodynamic activation of ionic channel TRPA1. Protein photosensitizers have been used to photodynamically modulate major cellular functions (such as neurotransmitter release and gene transcription) and animal behavior. Protein photosensitizers are increasingly used in photon-driven nanomanipulation in cell physiology research.
Keywords: photosensitization, protein photosensitizer, photonanomanipulation, singlet oxygen, calcium oscillation, pancreatic acinar cells, photopharmacology, ligand-independent
Introduction
Photodynamic action as a physiological curiosity has a long history, dating back to more than a century ago (for an early review on this topic, please see Blum, 1932). Investigation of photodynamic modulation of cellular physiology, however, has been rather limited until the recent past. A number of technological advances in photodynamic research have been made in the past few years. The newly renovated photodynamic modulation is now poised to be used on a much wider scale in physiological research.
A typical photodynamic action involves light, light-absorbing organic molecule (photosensitizer, S), and oxygen. Singlet oxygen is generated in a Type II photodynamic action. The photosensitizer (S) after absorption of a photon (hυ) of appropriate wavelength is excited from ground state (S) to the singlet excited state (1S). The 1S then undergoes a physical process named intersystem crossing (isc), to reach the triplet excited state (3S). If the triplet state is sufficiently long-lived, its excitation energy can be transferred to the ground state molecular oxygen (1), to generate the delta singlet oxygen (1Δg)(1O2). The singlet oxygen so generated can react with cellular components (A), to trigger the full-scale cellular photodynamic responses (Cui and Matthews, 1998; Cui et al., 2012; Dai et al., 2012) (Scheme 1).
Uncontrolled photodynamic action is detrimental as noted in porphyria patients (Kaestner et al., 2004; Norman, 2005), but measured photodynamic action has been utilized for major clinical advances. Concentrated generation of singlet oxygen at mega doses is cytocidal in different patterns (Agostinis et al., 2011; Krammer and Verwanger, 2012; Bacellar et al., 2015; Abrahamse and Hamblin, 2016). Singlet oxygen could trigger apoptosis, for example, by oxidizing multiple proteins (such as Bcl-2, Bcl-XL, BAX, BID) in the apoptosis pathway (Oleinick and Evans, 1998; Xue et al., 2001; Usuda et al., 2002, 2003; Chiu et al., 2005; Wan et al., 2008; Liu et al., 2011). Due to such cytocidal effects of singlet oxygen, photodynamic action has been found to be effective in the clinical treatments of both cancers and non-malignant lesions (Kennedy et al., 1990; Bown et al., 2002; Mittra and Singerman, 2002; Brown et al., 2004; Szeimies et al., 2010; Agostinis et al., 2011; Bown, 2013; Huggett et al., 2014; Craig et al., 2015; Abrahamse and Hamblin, 2016; Liu et al., 2016; Newman, 2016). On the other hand, it has been found that controlled doses of singlet oxygen could modulate cellular signaling in different cell types such as glandular cells with proven high specificity (Matthews and Cui, 1989, 1990a,b; al-Laith et al., 1993; Cui and Kanno, 1997; Cui et al., 1997, 2000, 2003, 2012; Cui and Matthews, 1998; Hashikura et al., 2001; Cui and Guo, 2002a,b; An et al., 2003; Wang et al., 2003; Krammer and Verwanger, 2012; Bacellar et al., 2015). One particular noted case is the photodynamic activation of CCK1 receptors in rat pancreatic acinar cells.
Singlet oxygen and its permanent activation of CCK1 receptor
Singlet oxygen generated in photodynamic action with the sulphonated aluminum phthalocyanine (SALPC), has been found to activate rather permanently the CCK1 receptor in rat pancreatic acinar cells (Cui and Kanno, 1997; An et al., 2003; Cui et al., 2012), but desensitizes the α1 adrenergic receptor in rat hepatocytes (Cui et al., 2000) and other G protein-coupled receptors (GPCR).
CCK-CCK receptors play important roles in both gastrointestinal (GI) and central nervous system (CNS) functions (Cawston and Miller, 2010; Yu and Smagghe, 2014), due to the wide-spread distribution of both CCK1 and CCK2 receptors (Miller and Gao, 2008; Dockray and Burdyga, 2011). Of the group A GPCR receptors, CCK1 is unique in that it can be permanently activated by photodynamic oxidation (Cui and Kanno, 1997; An et al., 2003; Cui et al., 2012). It may be noted that ligand (agonist CCK)-induced cytosolic calcium oscillations disappeared immediately after washout of CCK (Figure 1A), but the photodynamically-induced, ligand-independent calcium oscillations persisted well after photodynamic action (duration: 1 min) had completed (Figure 1B).
An early hint for irreversible activation of CCK1 receptor was noted as early as 1980 by the Jamieson group. A photoaffinity probe to label the CCK1 receptor, CCK octapeptide (Asp-Tyr-(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2, CCK-8) analog 2-nitro-5-azidobenzoyl-Gly-Asp-Tyr-(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2 (NAB-Gly-CCK-8), was found to elicit irreversible secretion after UV irradiation of guinea pig pancreatic acini, although whether such secretion was mediated by the CCK1 receptor was not at that time verified (Galardy et al., 1980). A series of works by us have clearly delineated the irreversible nature of oxidative activation of CCK1 receptor (Matthews and Cui, 1989, 1990a,b; al-Laith et al., 1993; Cui et al., 1997, 2012; Cui and Kanno, 1997; An et al., 2003).
Photodynamic action with the photosensitizer sulphonated aluminum phthalocyanine (SALPC) was initially found to stimulate amylase secretion and regulate cytosolic signaling in the freshly isolated rat pancreatic acini (as reviewed in Cui and Matthews, 1998). In those experiments, the freshly isolated pancreatic acini were perifused, exposed to SALPC briefly (10 min), subsequent light illumination (2 min) then triggered persistent calcium oscillations which were completely blocked by CCK1 antagonist FK480 (10 nM) (An et al., 2003) (Figure 1C). After the blockade of calcium oscillations with FK480 (10 nM), the muscarinic agonist bethanechol (Beth) still triggered robust new calcium oscillations (An et al., 2003) (Figure 1C). These data indicated that after photodynamically-triggered calcium oscillations, pancreatic acinar cells remained perfectly healthy (An et al., 2003; Cui et al., 2012). Here the photodynamic action was restricted to the plasma membrane (Cui and Kanno, 1997; An et al., 2003; Cui et al., 2012).
Protein photosensitizer for nanoscopically-confined photodynamic action
Singlet oxygen in the cellular milieu has a short lifetime (μs) (Cui and Matthews, 1998; Bovis et al., 2012; Kim et al., 2014), therefore has a limited effective diffusion distance of <10 nm (Moan and Berg, 1991; Cui and Matthews, 1998; Dougherty et al., 1998; Nowis et al., 2005; Cui et al., 2012). Singlet oxygen generated in photodynamic action is, therefore, effective only at the site of generation, or at the site of photosensitizer localization in the cell.
Due to their intrinsic physicochemical properties, photosensitizers of different chemical classes tend to accumulate preferentially at specific subcellular sites such as the plasma membrane, the endoplasmic reticulum (ER), lysosomes, mitochondria, to modulate cellular activities from their different subcellular locations after photodynamic action (Theodossiou et al., 2006; Allison and Sibata, 2010; Agostinis et al., 2011). Hematoporphyrin derivative (HPD) monomers tend to accumulate at the mitochondria, and HPD oligomers at the plasma membrane (Scourides et al., 1987). Mono-aspartyl chlorin e6 (MACE) after endocytosis localizes to lysosomes (Berg and Moan, 1997). Phthalocyanines tend to accumulate at mitochondria (Peng et al., 1991). Benzoporphyrin derivative (BpD) is localized to the Golgi apparatus (Rosenkranz et al., 2000). Protoporphyrin IX (PPIX) precursor ALA-synthesized PPIX distributes to the plasma membrane, lysosomes and mitochondria (Kennedy et al., 1990).
Interestingly, photodynamic action at different cellular sites triggers cell death by distinct pathways. Photodynamic action at mitochondria and lysosomes triggers apoptosis; photodynamic action at the ER elicits autophagy; whereas photodynamic action at the plasma membrane induces necrosis (Almeida et al., 2004; Bacellar et al., 2015; Abrahamse and Hamblin, 2016). As mentioned above, SALPC photodynamic action at the plasma membrane induced permanent activation of CCK1 receptor (Cui and Kanno, 1997; An et al., 2003; Cui et al., 2012), photodynamic action with Victoria Blue VO at mitochondria reduced the oscillatory frequency of receptor-mediated calcium oscillations (Cui and Guo, 2002a,b).
It is recognized that the specific localization of chemical photosensitizers are only relative, distribution in multiple subcellular sites are quite common (Kessel, 1997, 2004, 2012; Kessel et al., 1997; Oleinick and Evans, 1998). The plasma membrane-localized photosensitizer MCP, for example, is also found in the ER and lysosomes; photosensitizer SnOPA is present in the plasma membrane, but also in the ER, lysosomes and elsewhere (for an in-depth review, see Kessel, 2004).
Mutated fluorescent proteins or engineered flavin-binding proteins have significantly enhanced photosensitivity compared with their parental proteins. Such genetically-encoded protein photosensitizers can be targeted precisely to subcellular organelles after tagging with signal sequences or after fusion with target proteins, resulting in high-precision spatially-controlled photodynamic action, or targeted protein oxidation. Locally-expressed protein photosensitizers after absorption of photons at specified wavelength generate the highly reactive singlet oxygen. Singlet oxygen as noted above has limited diffusion distance (<10 nm), therefore modulates target proteins or subcellular organelles nanoscopically.
Individual protein photosensitizers
Protein photosensitizers are either fluorescent protein variants such as KillerRed, KillerOrange, TagRFP, or flavin-binding proteins such as miniSOG and variants miniSOGQ102L/V, and Pp2FbFPL30M. The miniSOGQ102L is also named by some as singlet oxygen protein photosensitizer (SOPP). The chromophores (fluorophores) of KillerRed, KillerOrange, TagRFP are QYG, QWG, MYG, respectively, whereas miniSOG, miniSOGQ102L/V, Pp2FbFPL30M all share the same chromophore of FMN (Figure 2).
KillerRed
The prototypical protein photosensitizer KillerRed is derived from the jellyfish chromoprotein anm2CP (239 residues, MWt 27 kD) (Bulina et al., 2006a,b; Pletnev et al., 2009), with point mutations of Thr145Asp, Cys161Gly (Shagin et al., 2004). KillerRed is composed of 11 anti-parallel β-sheets which form a barrel structure, with a central chromophore of Q65-Y66-G67 (see Figure 2) (Roy et al., 2010). An aqueous central channel/pore exists in the KillerRed structure, which is composed of the chromophore Q65-Y66-G67 and residues Ile142, Leu143, Pro144, Ile199, Ile200, Thr201. The excited chromophore can transfer its excitation energy to ground state molecular oxygen which has reached the chromophore region by diffusion through this channel; the generated ROS also exit KillerRed via the same channel (Carpentier et al., 2009; Pletnev et al., 2009; Serebrovskaya et al., 2009; Roy et al., 2010). The ROS quantum yield of KillerRed is more than 1000 times of EGFP (Bulina et al., 2006a,b; Carpentier et al., 2009; Pletnev et al., 2009). The current consensus is that KillerRed undergoes a Type I photodynamic action to generate superoxide anion, although it was previously thought to generate singlet oxygen by a Type II photodynamic action (Pletnev et al., 2009; Serebrovskaya et al., 2009; Shu et al., 2011; Vegh et al., 2011; Kim et al., 2014). A singlet oxygen-generating capacity cannot be completely ruled out, however (Roy et al., 2010; Petrova et al., 2016). Since KillerRed tends to dimerize, a monomeric mutant, Supernova, has been reported (Figure 2), which has the following 6 mutations compared with KillerRed: G3V, N145S, L160T, F162T, L172K, M204T (Takemoto et al., 2013). Supernova is believed to have similar photochemical properties as the parental KillerRed (Takemoto et al., 2013). The basic characteristics of KillerRed are listed in Table 1 (Bulina et al., 2006a,b; Lukyanov et al., 2010). Further mutations (G5C, Y68W, D119S, N147S, F179L, Y223H, E237Q) of KillerRed result in a blue-shifted KillerOrange, the photosensitization properties of KillerOrange remain to be investigated (Pletneva et al., 2015; Sarkisyan et al., 2015).
Table 1.
Photosensitizer | No. AA | λex (nm) | λem (nm) | Φ1O2 | Φfluo |
---|---|---|---|---|---|
KillerRed | 239 | 585 | 610 | (−) | 0.25 |
KillerOrange | 239 | 512 | 550 | ND | 0.42 |
TagRFP | 237 | 555 | 584 | 0.004 | 0.48 |
miniSOG | 106 | 448 | 500 | 0.03 | 0.45 |
Pp2FbFPL30M | 148 | 449 | 495 | 0.09 | 0.25 |
miniSOGQ102L/V | 106 | 440 | 487 | 0.25/0.39 | 0.43 |
NO. AA, number of amino acid residues; λex, excitation wavelength; λem, emission wavelength; Φ1O2, singlet oxygen quantum yield; Φfluo, fluorescence quantum yield; (−), Only is produced; ND, Not done.
KillerRed fused with signal sequences can be targeted to the mitochondria in 293T cells (Bulina et al., 2006b), HEK293 cells, in the body wall muscle cells (Shibuya and Tsujimoto, 2012) and neurons of C. elegans (Williams et al., 2013). KillerRed can also be targeted to the lysosomes (Serebrovskaya et al., 2014), Golgi apparatus (Jarvela and Linstedt, 2014), the plasma membrane, mitochondria, or chromosomes (Shirmanova et al., 2013) in Hela cells. KillerRed has also been targeted to the plasma membrane in C. elegans neurons (Williams et al., 2013), zebrafish neurons and cardiomyocytes (Lee et al., 2010; Teh et al., 2010), or targeted to chromosomes in DU145 cells (Waldeck et al., 2011). The fusion protein TRF1-KillerRed has been used to target the telomeres (Sun et al., 2015). KillerRed fusion proteins (laminB1-KillerRed/histone2A-KillerRed) have been used to determine the spatial localization of chromosomal genes in the cell nucleus (Waldeck et al., 2013). The histone fusion protein H2B-KillerRed can be used to exert photodynamic blockade of cell division (Serebrovskaya et al., 2011; Shirmanova et al., 2015). Light irradiation of mitochondria-localized KillerRed (Mito-KillerRed) has been used to prune neuronal dendritic spines in defined dendritic regions of cultured neurons via the induction of caspase-3 activity (Ertuerk et al., 2014). Work done with larval zebrafish expressing KillerRed in the habenula afferent neurons from the ventral-lateral forebrain has helped to confirm that the habenula region is important for avoidance learning and helpless behavior (Lee et al., 2010).
TagRFP
TagRFP is derived from the Entacmaea quadricolor fluorescent protein TurboRFP (a random mutant of eqFP578), with mutations of R162E, Q166D, S180N, F198V, F200Y at the hydrophilic interface (Merzlyak et al., 2007). TagRFP has a central chromophore of M63-Y64-G65 (Subach et al., 2010). Light irradiated-TagRFP generates only 1O2, with a quantum yield of 0.004, but does not produce superoxide anion (Ragas et al., 2011). TagRFP has a high fluorescent quantum yield (Φfluo 0.48) and is widely used for fluorescent imaging (Merzlyak et al., 2007; Khrenova et al., 2015; Manoharan et al., 2015) (see Table 1). But when using TagRFP as a fluorescent probe for imaging, care must be taken that no undue photodamage is induced in either live cells or fixed tissue sections. Light illumination (532 nm, 40 mWatt/cm2) of TagRFP-expressing E. coli has been found to result in bacterial cell death (Ruiz-González et al., 2012).
miniSOG
The flavin-binding protein miniSOG is derived from the LOV2 domain of A. thaliana phototropin 2 with a Cys426Gly mutation, with further mutations S24G, I387M, N390S, S394T, F470L surrounding the chromophore (FMN) binding site (Shu et al., 2011). The resultant miniSOG is composed of 2 α-helix, interspersed with 5 β-sheets, with the chromophore FMN located between the α-helix and β-sheets (Pietra, 2014) (see Figure 2). Point mutation Cys426Gly facilitates transfer of FMN excitation energy absorbed from a photon to ground state O2 instead of to covalent bonding with Cys, significantly enhancing its 1O2 quantum yield (Shu et al., 2011). Initial report with anthracene-9, 10-dipropionic acid (ADPA) as the 1O2 probe obtained a quantum yield of 0.476 (Shu et al., 2011). Subsequent work has found that ADPA is also oxidized by other ROS (Ruiz-González et al., 2012). Direct measurement of 1O2 phosphorescence at 1275 nm, and the use of uric acid or PNS as 1O2 probes revealed a much lower quantum yield of 0.03 (Ruiz-González et al., 2012; Pimenta et al., 2013). The basic spectroscopic characteristics of miniSOG are listed in Table 1 (Shu et al., 2011; Ryumina et al., 2013; Wingen et al., 2014; Westberg et al., 2015).
Photosensitizer miniSOG can be targeted to the plasma membrane, mitochondria or chromosomes in Hela cells (as fusion proteins miniSOG-mem, miniSOG-mito, H2B-miniSOG) (Ryumina et al., 2013). In C. elegans motor neurons, miniSOG-TOMM-20 is targeted to mitochondrial outer membrane, whereas miniSOG-COX8a is targeted to mitochondrial matrix (Qi et al., 2012). miniSOG can be expressed as a fusion protein with the SDHC subunit (mev-1) of the mitochondrial respiratory chain complex II (succinate:ubiquinone oxidoreductase), to photodynamically inactivate with high specificity the respiratory chain complex II (on mitochondrial inner membrane) in C. elegans, without any damage toward its immediate neighbors complex I (NADH:ubiquinone oxidoreductase) or complex IV (cytochrome C oxidase) (Wojtovich et al., 2016). Photosensitizer miniSOG has also been fusion-expressed with vesicular SNARE proteins vesicule-associated membrane protein 2 (VAMP2) or synaptophysin 1 (SYP1), to target the small synaptic vesicles in cultured rat hippocampal neurons (Lin et al., 2013) or C. elegans neurons (Lin et al., 2013). miniSOG could be fusion-expressed with the synaptic active zone protein Munc13, to the pre-synaptic active zone in C. elegans neurons (Zhou et al., 2013).
Pp2FbFPL30M
Pp2FbFPL30M is derived from the LOV domain of the flavin-binding protein Pp2FbFP from Pseudomonas sputita, with a further mutation of L30M (Torra et al., 2015). Measurement of phosphorescence at 1275 nm found that the 1O2 quantum yield of Pp2FbFPL30M was 0.09 (Torra et al., 2015). The spectroscopic characteristics of Pp2FbFPL30M) are listed in Table 1 (Ryumina et al., 2013; Wingen et al., 2014).
SOPP
miniSOGQ102L is also named SOPP, as mentioned above. In comparison with the parental miniSOG, in SOPP the FMN-binding glutamine is mutated to leucine (Q102L). This mutation reduces the hydrogen bond between Q102 and FMN, diminishing electron transfer, but enhancing energy transfer, with the net result of a much enhanced 1O2 quantum yield of 0.25 (Westberg et al., 2015, 2016). Another mutant, miniSOGQ102V (Figure 2), has an even higher 1O2 quantum yield of 0.39 (Rodríguez-Pulido et al., 2016). When miniSOGQ102L is expressed at the plasma membrane (by fusion with a PH domain) in C. elegans epithelial cells or in the cholinergic neurons, blue light illumination induces worm paralysis and neuronal injury, at efficiency higher than with miniSOG as the photosensitizer (Xu and Chisholm, 2016). The basic properties of miniSOGQ102L are listed in Table 1. A new version of miniSOG, miniSOG2, involves seven point mutations: G22S, G40P, Q44R, R57H, L84F, H85R, M89I. Mutations R57H, Q44R, G40P, L84F directly interacting with the chromophore FMN are likely responsible for the red-shifted excitation and emission spectra, together with enhanced singlet oxygen generation, but the quantum yield remains to be measured (Makhijani et al., 2017).
Targeted subcellular expression of protein photosensitizers
Subcellular targeting of protein photosensitizers has been done as mentioned above in different cell types, such as targeted KillerRed expression in Hela cells (Shirmanova et al., 2013; Jarvela and Linstedt, 2014; Serebrovskaya et al., 2014), HEK293 cells (Bulina et al., 2006b), DU145 cells (Waldeck et al., 2011), and miniSOG expression in Hela cells (Ryumina et al., 2013) or in cultured hippocampal neurons (Lin et al., 2013).
To target-express a protein photosensitizer, the photosensitizer gene needs to be fused with a subcellular localization sequence (SLS), to localize the protein photosensitizer to the desired subcellular compartments. KillerRed, for example, could be targeted to the plasma membrane (Bulina et al., 2006b; Teh et al., 2010) (plasma membrane LS, PMLS) with the N-terminal (20 residues) sequence of neuromodulin (Skene and Virág, 1989), or with the PH Delta1 sequence (Fujii et al., 1999; Bulina et al., 2006b). KillerRed can be targeted to mitochondria with the double sequences of MTS1 and MTS2 (Yang and Yang, 2011; Shibuya and Tsujimoto, 2012). Mitochondrial targeting sequence (MTS) can be derived from human cytochrome C oxygenase VIII subunit (Rizzuto et al., 1989, 1995), or from members of the respiratory chain complexes (Wojtovich et al., 2016). For lysosomal targeting, the C-terminal cytosolic tail sequence of the lysosomal-associated membrane protein II (LIMP II) could be used (Tabuchi et al., 2000). GTPase Rab7A sequence has been used to target KillerRed to lysosomes (Serebrovskaya et al., 2011; Ryumina et al., 2016). ER targeting could use the ER localization sequence (MLLSVPLLLGLLGLAVA) of calreticulin (Fliegel et al., 1989) and the ER retaining sequence KDEL (Munro and Pelham, 1987). The human β-1,4-galactotransferase N-terminal sequence can be used to target TagRFP to the Golgi apparatus (Shaner et al., 2008). Fusion proteins miniSOG-H2B, miniSOG-VAMP2, SYP1-miniSOG as mentioned above target miniSOG to Hela cell chromosomes (Ryumina et al., 2013), and to the small synaptic vesicles, respectively (Lin et al., 2013). KillerRed-TRF1 targets to the telomeres (Sun et al., 2015). The complete amino acid sequence of protein photosensitizers are listed in Table 2.
Table 2.
KillerRed (Bulina et al., 2006a) | ||||||
1 | MGSEGGPALF | QSDMTFKIFI | DGEVNGQKFT | IVADGSSKFP | HGDFNVHAVC | ETGKLPMSWK |
61 | PICHLIQYGE | PFFARYPDGI | SHFAQECFPE | GLSIDRTVRF | ENDGTMTSHH | TYELDDTCVV |
121 | SRITVNCDGF | QPDGPIMRDQ | LVDILPNETH | MFPHGPNAVR | QLAFIGFTTA | DGGLMMGHFD |
181 | SKMTFNGSRA | IEIPGPHFVT | IITKQMRDTS | DKRDHVCQRE | VAYAHSVPRI | TSAIGSDED |
SuperNova (Takemoto et al., 2013) | ||||||
1 | MGSEVGPALF | QSDMTFKIFI | DGEVNGQKFT | IVADGSSKFP | HGDFNVHAVC | ETGKLPMSWK |
61 | PICHLIQYGE | PFFARYPDGI | SHFAQECFPE | GLSIDRTVRF | ENDGTMTSHH | TYELDDTCVV |
121 | SRITVNCDGF | QPDGPIMRDQ | LVDILPSETH | MFPHGPNAVR | QTATIGFTTA | DGGKMMGHFD |
181 | SKMTFNGSRA | IEIPGPHFVT | IITKQTRDTS | DKRDHVCQRE | VAYAHSVPRI | TSAIGSDED |
KillerOrange (Pletneva et al., 2015) | ||||||
1 | MGSECGPALF | QSDMTFKIFI | DGEVNGQKFT | IVADGSSKFP | HGDFNVHAVC | ETGKLPMSWK |
61 | PICHLIQWGE | PFFARYPDGI | SHFAQECFPE | GLSIDRTVRF | ENDGTMTSHH | TYELSDTCVV |
121 | SRITVNCDGF | QPDGPIMRDQ | LVDILPSETH | MFPHGPNAVR | QLAFIGFTTA | DGGLMMGHLD |
181 | SKMTFNGSRA | IEIPGPHFVT | IITKQMRDTS | DKRDHVCQRE | VAHAHSVPRI | TSAIGSDQD |
TagRFP (Ruiz-González et al., 2012) | ||||||
1 | MVSKGEELIK | ENMHMKLYME | GTVNNHHFKC | TSEGEGKPYE | GTQTMRIKVV | EGGPLPFAFD |
61 | ILATSFMYGS | RTFINHTQGI | PDFFKQSFPE | GFTWERVTTY | EDGGVLTATQ | DTSLQDGCLI |
121 | YNVKIRGVNF | PSNGPVMQKK | TLGWEANTEM | LYPADGGLEG | RSDMALKLVG | GGHLICNFKT |
181 | TYRSKKPAKN | LKMPGVYYVD | HRLERIKEAD | KETYVEQHEV | AVARYCDLPS | KLGHKLN |
miniSOG (Shu et al., 2011) | ||||||
1 | MEKSFVITDP | RLPDNPIIFA | SDGFLELTEY | SREEILGRNG | RFLQGPETDQ | ATVQKIRDAI |
61 | RDQREITVQL | INYTKSGKKF | WNLLHLQPMR | DQKGELQYFI | GVQLDG | |
Pp2FbFPL30M (Torra et al., 2015) | ||||||
1 | MINAKLLQLM | VEHANDGIVV | AEQEGNESIM | IYVNPAFERL | TGYCADDILY | QDARFLCGED |
61 | HDQDGIAIIR | EAIREGRPCC | QVLRNYRKDG | SLFWNELSIT | PVHNEADQLT | YYIGIQRDVT |
121 | AQVFAEERVR | ELEAEVAELR | RQQGQAKH | |||
SOPP/miniSOGQ102L/V (Westberg et al., 2015; Rodríguez-Pulido et al., 2016) | ||||||
1 | MEKSFVITDP | RLPDNPIIFA | SDGFLELTEY | SREEILGRNG | RFLQGPETDQ | ATVQKIRDAI |
61 | RDQREITVQL | INYTKSGKKF | WNLLHLQPMR | DQKGELQYFI | GVLLDG |
Protein photosensitizers (noted residues are shown in bold type and underlined, for details see text).
For whole organism studies, it is routine to place the desired gene under cell type- or tissue-specific promoters. Place the protein photosensitizer gene or gene construct under a suitable promoter, the sensitizer could then be expressed in that tissue (neuron, muscle, for example) only, in model animals C. elegans, zebrafish or others at the desired subcellular compartments (Serebrovskaya et al., 2011, 2014; Kobayashi et al., 2013; Williams et al., 2013). Cell-type specific viral vectors are also useful for in vivo injections. Engineered Muller cell-specific adenovirus variant containing the KillerRed gene, ShH10-KillerRed, for example, has been used to target the mouse retinal Muller cells. This study has confirmed the essential roles of Muller cells in visual perception and in normal retinal structure formation (Byrne et al., 2013). In this regard some technical strategies for gene delivery (Kaestner et al., 2015a; El-Shamayleh et al., 2016) and past works on tissue-specific expression of fluorescent protein sensors may be considered (Akemann et al., 2013; Kaestner et al., 2015b).
Selective illumination of defined regions for localized photodynamic action
Other than subcellularlly-defined expression of protein photosensitizers, photodynamic action could be further spatially-delimited with ultra-structurally distinct point illumination. The recently emerged active illumination (AI) technology can be done at single or dual wavelengths, in multiple cells or cellular regions, simultaneously with imaging. The illumination light spot could vary in size, shape, and light intensity, with the spot size down to the theoretical diffraction limit (0.2 × 0.2 μm) (Shkryl et al., 2012). Active or selective illumination is made possible due to the invention of digital micromirror arrays, which can in real-time control the angle of each micromirror in the array (Shkryl et al., 2012).
Such selective illumination has been used to un-cage calcium or inositol 1, 4, 5-triphosphate (IP3) at multiple cellular sites simultaneously (Shkryl et al., 2012). Selective dual-wavelength illumination (390, 510 nm) could open or close, in tandem, designer photosensitive potassium channels in neurons (Janovjak et al., 2010). It has been shown that after selective irradiation of cultured vascular endothelial cells, localized photodynamic action readily triggered focused cell death in the irradiated areas (Feine et al., 2012). In channelrhodopsin 2 (ChR2)-expressing C. elegans, selective illumination of dendrites of sensory neurons stimulated cytosolic calcium increase, leading to enhanced worm activities (Cho and Sternberg, 2014).
Highlighted examples of photodynamic modulation of cellular physiology
Photodynamic modulation of cellular functions with protein photosensitizers is outlined above. Works in the following areas have emerged which are of particular significance in cellular physiology.
Modulation of ionic channels
The earliest example of photodynamic modulation of native ionic channels is illustrated by the photodynamic blockade, with photosensitizers Rose Bengal and Eosin Y, of voltage-gated sodium channels (Nav) in the squid giant axons. In addition, photodynamic action also slowed or disrupted Nav inactivation (Oxford et al., 1977). Photodynamic action with Rose Bengal has also been found to inhibit other voltage-gated channels as well (Nav, Kv, Cav) in the isolated frog (Rana pipiens) atrial cardiomyocyte. After photodynamic action, Nav inactivation was significantly slowed; Cav inactivation was also inhibited (Tarr and Valenzeno, 1991). Photodynamic action with Rose Bengal was found to inhibit Cav, Kv, KCa channels in rat anterior pituitary cells GH3 (Valenzeno and Tarr, 1997).
Kv channels expressed in cell lines have been found to be inhibited by photodynamic action with porphyrins (photosensitizer) conjugated to subtype-specific monoclonal antibodies. Photodynamic action with anti-Kv4.2 mAb-porphyrin conjugates was found to facilitate photoablation of Kv4.2, but not of Kv4.3 or Kv2.1 (Sack et al., 2013). Similarly photodynamic action (laser light at 473 nm, 350 mW/cm2) with channel-binding photosensitizer FITC-cAMP (bound to CNBD in mHCN2) was found to inhibit mouse potassium channel mHCN2 expressed in Xenopus laevis oocytes. Photodynamic modulation of mHCN2 in the closed state decreased subsequently induced Ih current significantly. In contrast, photodynamic action enhanced the Iinst current and delayed channel inactivation when photosensitization was executed in the open channels (Gao et al., 2014). These latter two photodynamically-induced changes were determined to be due to oxidation or cross-linking of the His434 residue located at the cytosolic side of the S6 segment, because H434A mutation abolished the delay in channel deactivation, and the generation of Iinst (Gao et al., 2014). Interestingly, when miniSOG was fused to the C terminal end (C terminal end of CNBD) of mHCN2, light irradiation was found to exert (on mHCN2) effects similar to those observed with the chemical photosensitizer FITC-cAMP (Gao et al., 2014).
In contrast to the inhibitory effect on the voltage-gated channels Nav and Kv, photo-oxidation has been found to activate the calcium-permeant sensory channels TRPA1 and TRPV1 (Hill and Schaefer, 2009; Babes et al., 2016). Photodynamic action with photosensitizers acridine orange (490 nm), or hypericin (590 nm) was found to activate TRPA1 expressed in HEK293 cells (Hill and Schaefer, 2009). Photodynamic action with photosensitizer protoporphyrin IX was found to drastically activate both TRPA1 and TRPV1. Purified human TRPA1 inserted in artificial lipid bilayers was found to be activated only after photodynamic action with protoporphyrin IX and blue light (Babes et al., 2016) (Figure 3). Similar works involving the protein photosensitizers both ex vivo and in vivo are eagerly awaited.
Modulation of the exocytotic SNARE complex
The SNARE complex proteins and associated synaptic active zone proteins are essential for regulated neurotransmitter release. Protein photosensitizer miniSOG fused with the v-SNARE proteins VAMP2 or synaptophysin (miniSOG-VAMP2, SYP1-miniSOG) was expressed in neonatal rat hippocampal slices or in cultured hippocampal and cortical neurons. Transgenic C. elegans worms with panneuronal expression of miniSOG-VAMP2 were also made. The fused miniSOG (miniSOG-VAMP2, SYP1-miniSOG) was found to localize to the synaptic vesicles, but without any effect on transmitter release or on animal behavior in the dark. Upon illumination with blue light (480 nm), neurotransmitter release in cultured neurons or in hippocampal slices were completely blocked, with the inhibition lasting for >1 h (Lin et al., 2013). In C. elegans panneuronally expressing miniSOG-VAMP2, light irradiation similarly led to marked inhibition of spontaneous neurotransmitter release, with reduced movement and worm paralysis (Lin et al., 2013). Light irradiation (480 nm) of C. elegans expressing miniSOG fused to the pre-synaptic active zone protein Munc13 led to similar acute inhibition of neurotransmitter release (Zhou et al., 2013) (Figure 4).
Modulation of nuclear events
Another place of interest that has been investigated is the chromosomal tip, the telomeres. The photosensitizer KillerRed could be fusion-expressed with the telomere repeat binding factor 1 (KillerRed-TRF1). The spatially-defined generation of singlet oxygen after photodynamic action at the telomeres was found to result in telomere abnormalities (telomere associations, shortened or complete loss of telomeres), leading to fastened cell senescence or cell death in cultured cancer cells HeLa, U2OS and IMR90 (Sun et al., 2015) (Figure 5A). KillerRed fusion expressed with the chromosomal protein histone H2B (H2B-KR-KR) in adherent HeLa-Kyoto cells after green light illumination was found to induce acute wide spread damages to genomic DNA, leading to non-separation of chromosomes, and to blockade of cell division and proliferation. H2B-KR-KR target expressed in specific tissues (under control of tissue-specific promoters) in Xenopus embryos was found, after green light illumination (540–580 nm 120 mW/cm2; 525 nm, 45 mW/cm2), to retard organogenesis. Therefore, H2B-KR-KR photodynamic action could be used to study cell division, organism development, organogenesis or carcinogenesis in a cell-specific manner in vivo (Serebrovskaya et al., 2011) (Figure 5B). Protein photosensitizers tandem-KillerRed and miniSOG target-expressed at chromatin (H2B-tKR or H2B-miniSOG) in HeLa-Kyoto cells after brief light irradiation (H2B-tandem KillerRed expressing cells with green light 540–580 nm for 15 min at 200 mW/cm2; H2B-miniSOG for 5 min with blue light 465–495 nm at 65 mW/cm2) was able to induce single strand breaks but only miniSOG induced double strand breaks of the genomic DNA, leading to DNA damage response and cell senescence (Petrova et al., 2016). Most interestingly, germline C. elegans expressing Histone-mSOG after exposure to blue light has been found to produce progenies with inheritable phenotypes (Noma and Jin, 2015). KillerRed fusion-expressed either with the peripheral nuclear protein lamin B1 (KRed-Lamin B1) or with the diffusely distributed chromosomal protein H2A (H2A-KRed) was used to identify gene damages after photodynamic action. The extent of photo-oxidative damage was used to delineate the spatial localization of the respective genes and the gene-carrying chromosomes in the nucleus (Waldeck et al., 2013). KillerRed fused to a tet-repressor (tetR-KR) or a transcription activator (TA-KR) have been used to target oxidative stress to hetero- or euchromatin respectively in U2OS cells (Lan et al., 2014).
The above examples showcase targeted photonanomanipulation in subcellular organelle-based events at the plasma membrane, synaptic vesicles and at chromosomes. Numerous other subcellular sites can be similarly modulated with this light-controlled nanomanipulation technique.
Conclusion and perspectives
In conclusion, the emergence of protein photosensitizers with enhanced singlet oxygen quantum yield has made possible the fast-track progress in photodynamic nanomanipulation of cellular physiology, mainly in C. elegans and zebrafish, whole organism works in mammalian animals remain to be expanded. The targeted expression after insertion of signaling sequence, fusion expression of target proteins, or promoter-driven tissue-specific expression, have made possible highly confined generation of singlet oxygen, with targeted nanoscopical protein oxidative activation or inactivation. Of the three major photopharmacological techniques available today—optogenetics involving channelrhodopsin and other photosensory domain-containing proteins spatial configurational-responsive to the absorption of a photon, photochromic ligands of receptors or ionic channels involving the photon-driven configurational changes of small molecule ligands, and photodynamic modulation involving photosensitizer-generated singlet oxygen, the protein photosensitizers are unique in that they could be repetitively irradiated (used) rather like an enzyme molecule to generate multiple copies of singlet oxygen molecules but not merely repetitive configuration changes in the light-absorbing molecules themselves. This makes possible multiple-hit oxidative activation or desensitization of receptors and channels important in cellular physiology, with the use of attenuated lasers and LED, or with cheap halogen cold light sources. In the future, more extensive works may be done with this photonanomanipulation technique both in the elucidation of basic cellular functions such as gene transcription, protein synthesis, transport, degradation, or in the elucidation of cell-type specific functions in the central nervous system circuits or in the innervation hubs (ganglia) and pathways (nerve fiber wirings) of the peripheral nervous system. Such photonanomanipulations in situ could also be used to study the intrinsic long-term repair mechanisms with high spatial and temporal resolutions.
Author contributions
HJ and YL wrote the initial drafts. ZC conceived the idea of the review and finalized the last version of the article. All authors checked and approved the submitted version.
Funding
Work in the authors' laboratory has been supported by grants from The Natural Science Foundation of China (Nos. 31670856, 31270892) and The National Basic Research Program (973 Program) from The Ministry of Science and Technology of China (No. 2011CB809101).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
- Abrahamse H., Hamblin M. R. (2016). New photosensitizers for photodynamic therapy. Biochem. J. 473, 347–364. 10.1042/BJ20150942 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Agostinis P., Berg K., Cengel K. A., Foster T. H., Girotti A. W., Gollnick S. O., et al. (2011). Photodynamic therapy of cancer: an update. CA Cancer J. Clin. 61, 250–281. 10.3322/caac.20114 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Akemann W., Sasaki M., Mutoh H., Imamura T., Honkura N., Knoepfel T. (2013). Two-photon voltage imaging using a genetically encoded voltage indicator. Sci. Rep. 3:2231. 10.1038/srep02231 [DOI] [PMC free article] [PubMed] [Google Scholar]
- al-Laith M., Matthews E. K., Cui Z. J. (1993). Photodynamic drug action on isolated rat pancreatic acini. Mobilization of arachidonic acid and prostaglandin production. Biochem. Pharmacol. 46, 567–573. 10.1016/0006-2952(93)90539-9 [DOI] [PubMed] [Google Scholar]
- Allison R. R., Sibata C. H. (2010). Oncologic photodynamic therapy photosensitizers: a clinical review. Photodiagnosis Photodyn. Ther. 7, 61–75. 10.1016/j.pdpdt.2010.02.001 [DOI] [PubMed] [Google Scholar]
- Almeida R. D., Manadas B. J., Carvalho A. P., Duarte C. B. (2004). Intracellular signaling mechanisms in photodynamic therapy. Biochim. Biophys. Acta 1704, 59–86. 10.1016/j.bbcan.2004.05.003 [DOI] [PubMed] [Google Scholar]
- An Y. P., Xiao R., Cui H., Cui Z. J. (2003). Selective activation by photodynamic action of cholecystokinin receptor in the freshly isolated rat pancreatic acini. Br. J. Pharmacol. 139, 872–880. 10.1038/sj.bjp.0705295 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Babes A., Sauer S. K., Moparthi L., Kichko T., Neacsu C., Namer B., et al. (2016). Photosensitization in porphyrias and photodynamic therapy involves TRPA1 and TRPV1. J. Neurosci. 36, 5264–5278. 10.1523/JNEUROSCI.4268-15.2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bacellar I. O., Tsubone T. M., Pavani C., Baptista M. S. (2015). Photodynamic efficiency: from molecular photochemistry to cell death. Int. J. Mol. Sci. 16, 20523–20559. 10.3390/ijms160920523 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berg K., Moan J. (1997). Lysosomes. Microtubules as targets for photochemotherapy of cancer. Photochem. Photobiol. 65, 403–409. 10.1111/j.1751-1097.1997.tb08578.x [DOI] [PubMed] [Google Scholar]
- Blum H. F. (1932). Photodynamic action. Physiol. Rev. 12, 23–55. [Google Scholar]
- Bovis M. J., Woodhams J. H., Loizidou M., Scheglmann D., Bown S. G., MacRobert A. J. (2012). Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy. J. Control Release 157, 196–205. 10.1016/j.jconrel.2011.09.085 [DOI] [PubMed] [Google Scholar]
- Bown S. G. (2013). Photodynamic therapy for photochemists. Philos. Trans. A Math. Phys. Eng. Sci. 371:20120371. 10.1098/rsta.2012.0371 [DOI] [PubMed] [Google Scholar]
- Bown S. G., Rogowska A. Z., Whitelaw D. E., Lees W. R., Lovat L. B., Ripley P., et al. (2002). Photodynamic therapy for cancer of the pancreas. Gut 50, 549–557. 10.1136/gut.50.4.549 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown S. B., Brown E. A., Walker I. (2004). The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 5, 497–508. 10.1016/S1470-2045(04)01529-3 [DOI] [PubMed] [Google Scholar]
- Bulina M. E., Chudakov D. M., Britanova O. V., Yanushevich Y. G., Staroverov D. B., Chepurnykh T. V., et al. (2006a). A genetically encoded photosensitizer. Nat. Biotechnol. 24, 95–99. 10.1038/nbt1175 [DOI] [PubMed] [Google Scholar]
- Bulina M. E., Lukyanov K. A., Britanova O. V., Onichtchouk D., Lukyanov S., Chudakov D. M. (2006b). Chromophore-assisted light inactivation (CALI) using the phototoxic fluorescent protein KillerRed. Nature Protoc 1, 947–953. 10.1038/nprot.2006.89 [DOI] [PubMed] [Google Scholar]
- Byrne L. C., Khalid F., Lee T., Zin E. A., Greenberg K., Visel M., et al. (2013). AAV-mediated, optogenetic ablation of Muller glia leads to structural and functional changes in the mouse retina. PLoS ONE 8:e76075. 10.1371/journal.pone.0076075 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Carpentier P., Violot S., Blanchoin L., Bourgeois D. (2009). Structural basis for the phototoxicity of the fluorescent protein KillerRed. FEBS Lett. 583, 2839–2842. 10.1016/j.febslet.2009.07.041 [DOI] [PubMed] [Google Scholar]
- Cawston E. E., Miller L. J. (2010). Therapeutic potential for novel drugs targeting the type 1 cholecystokinin receptor. Br. J. Pharmacol. 159, 1009–1021. 10.1111/j.1476-5381.2009.00489.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chiu S. M., Xue L. Y., Azizuddin K., Oleinick N. L. (2005). Photodynamic therapy-induced death of HCT 116 cells: apoptosis with or without Bax expression. Apoptosis 10, 1357–1368. 10.1007/s10495-005-2217-0 [DOI] [PubMed] [Google Scholar]
- Cho J. Y., Sternberg P. W. (2014). Multilevel modulation of a sensory motor circuit during C. elegans sleep and arousal. Cell 156, 249–260. 10.1016/j.cell.2013.11.036 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Craig R. A., McCoy C. P., Gorman S. P., Jones D. S. (2015). Photosensitisers-the progression from photodynamic therapy to anti-infective surfaces. Expert Opin. Drug Deliv. 12, 85–101. 10.1517/17425247.2015.962512 [DOI] [PubMed] [Google Scholar]
- Cui Z. J., Guo L. L. (2002a). Assessing physiological concentrations of endogenous substances in situ by inducing calcium oscillations in vitro. Case of liver. Acta Pharmacol. Sin. 23, 27–32. [PubMed] [Google Scholar]
- Cui Z. J., Guo L. L. (2002b). Photodynamic modulation by Victoria Blue BO of phenylephrine-induced calcium oscillations in freshly isolated rat hepatocytes. Photochem. Photobiol. Sci. 1, 1001–1005. 10.1039/b208215m [DOI] [PubMed] [Google Scholar]
- Cui Z. J., Habara Y., Satoh Y. (2000). Photodynamic modulation of adrenergic receptors in the isolated rat hepatocytes. Biochem. Biophys. Res. Commun. 277, 705–710. 10.1006/bbrc.2000.3742 [DOI] [PubMed] [Google Scholar]
- Cui Z. J., Habara Y., Wang D. Y., Kanno T. (1997). A novel aspect of photodynamic action: induction of recurrent spikes in cytosolic calcium concentration. Photochem. Photobiol. 65, 382–386. 10.1111/j.1751-1097.1997.tb08574.x [DOI] [PubMed] [Google Scholar]
- Cui Z. J., Han Z. Q., Li Z. Y. (2012). Modulating protein activity and cellular function by methionine residue oxidation. Amino Acids 43, 505–517. 10.1007/s00726-011-1175-9 [DOI] [PubMed] [Google Scholar]
- Cui Z. J., Kanno T. (1997). Photodynamic triggering of calcium oscillation in the isolated rat pancreatic acini. J. Physiol. 504, 47–55. 10.1111/j.1469-7793.1997.047bf.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cui Z. J., Matthews E. K. (1998). Photodynamic modulation of cellular function. Acta Pharmacol. Sin. 19, 297–303. [PubMed] [Google Scholar]
- Cui Z. J., Zhou Y. D., Satoh Y., Habara Y. (2003). A physiological role for protoporphyrin IX photodynamic action in the rat Harderian gland? Acta Physiol. Scand. 179, 149–154. 10.1046/j.1365-201X.2003.01177.x [DOI] [PubMed] [Google Scholar]
- Dai T., Fuchs B. B., Coleman J. J., Prates R. A., Astrakas C., St Denis T. G., et al. (2012). Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front. Microbiol. 3:120. 10.3389/fmicb.2012.00120 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dockray G. J., Burdyga G. (2011). Plasticity in vagal afferent neurones during feeding and fasting: mechanisms and significance. Acta Physiol. (Oxf). 201, 313–321. 10.1111/j.1748-1716.2010.02219.x [DOI] [PubMed] [Google Scholar]
- Dougherty T. J., Gomer C. J., Henderson B. W., Jori G., Kessel D., Korbelik M., et al. (1998). Photodynamic therapy. J. Natl. Cancer Inst. 90, 889–905. 10.1093/jnci/90.12.889 [DOI] [PMC free article] [PubMed] [Google Scholar]
- El-Shamayleh Y., Ni A. M., Horwitz G. D. (2016). Strategies for targeting primate neural circuits with viral vectors J. Neurophysiol. 116, 122–134. 10.1152/jn.00087.2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ertuerk A., Wang Y. Y., Sheng M. (2014). Local pruning of dendrites and spines by caspase-3-dependent and proteasome-limited mechanisms. J. Neurosci. 34, 1672–1688. 10.1523/JNEUROSCI.3121-13.2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Feine I., Pinkas I., Salomon Y., Scherz A. (2012). Local oxidative stress expansion through endothelial cell - a key role for gap junction intercellular communication. PLoS ONE 7:e41633. 10.1371/journal.pone.0041633 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fliegel L., Burns K., MacLennan D. H., Reithmeier R. A., Michalak M. (1989). Molecular cloning of the high affinity calcium-binding protein (calreticulin) of skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 264, 21522–21528. [PubMed] [Google Scholar]
- Fujii M., Ohtsubo M., Ogawa T., Kamata H., Hirata H., Yagisawa H. (1999). Real-time visualization of PH domain-dependent translocation of phospholipase C-delta 1 in renal epithelial cells (MDCK): response to hypo-osmoticstress. Biochem. Biophys. Res. Commun. 254, 284–291. 10.1006/bbrc.1998.9936 [DOI] [PubMed] [Google Scholar]
- Galardy R. E., Hull B. E., Jamieson J. D. (1980). Irreversible photoactivation of a pancreatic secretagogue receptor with cholecystokinin COOH-terminal octapeptides. J. Biol. Chem. 255, 3148–3155. [PubMed] [Google Scholar]
- Gao W. H., Su Z. C., Liu Q. L., Zhou L. (2014). State-dependent and site-directed photodynamic transformation of HCN2 channel by singlet oxygen. J. Gen. Physiol. 143, 633–644. 10.1085/jgp.201311112 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hashikura S., Satoh Y., Cui Z. J., Habara Y. (2001). Photodynamic action inhibits compound 48/80-induced exocytosis in rat peritoneal mast cells. Jpn. J. Vet. Res. 49, 239–247. 10.14943/jjvr.49.3.239 [DOI] [PubMed] [Google Scholar]
- Hill K., Schaefer M. (2009). Ultraviolet light and photosensitising agents activate TRPA1 via generation of oxidative stress. Cell Calcium 45, 155–164. 10.1016/j.ceca.2008.08.001 [DOI] [PubMed] [Google Scholar]
- Huggett M. T., Jermyn M., Gillams A., Illing R., Mosse S., Novelli M., et al. (2014). Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer. Br. J. Cancer 110, 1698–1704. 10.1038/bjc.2014.95 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Janovjak H., Szobota S., Wyart C., Trauner D., Isacoff E. Y. (2010). A light-gated, potassium-selective glutamate receptor for the optical inhibition of neuronal firing. Nat. Neurosci. 13, 1027–1032. 10.1038/nn.2589 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jarvela T., Linstedt A. D. (2014). Isoform-specific tethering links the Golgi ribbon to maintain compartmentalization. Mol. Biol. Cell 25, 133–144. 10.1091/mbc.E13-07-0395 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kaestner L., Juzeniene A., Moan J. (2004). Erythrocytes–the house elves of photodynamic therapy. Photochem. Photobiol. Sci. 3, 981–989. 10.1039/B403127J [DOI] [PubMed] [Google Scholar]
- Kaestner L., Scholz A., Lipp P. (2015a). Conceptual and technical aspects of transfection and gene delivery. Bioorg. Med. Chem. Lett. 25, 1171–1176. 10.1016/j.bmcl.2015.01.018 [DOI] [PubMed] [Google Scholar]
- Kaestner L., Tian Q., Kaiser E., Xian W., Müller A., Oberhofer M., et al. (2015b). Genetically encoded voltage indicators in circulation research. Int. J. Mol. Sci. 16, 21626–21642. 10.3390/ijms160921626 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kennedy J. C., Pottier R. H., Pross D. C. (1990). Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B Biol. 6, 143–148. 10.1016/1011-1344(90)85083-9 [DOI] [PubMed] [Google Scholar]
- Kessel D. (1997). Subcellular localization of photosensitizing agents introduction. Photochem. Photobiol. 65, 387–388. 10.1111/j.1751-1097.1997.tb08575.x [DOI] [Google Scholar]
- Kessel D. (2004). Correlation between subcellular localization and photodynamic efficacy. J. Porphyr. Phthalocyanines 8, 1009–1014. 10.1142/S1088424604000374 [DOI] [Google Scholar]
- Kessel D. (2012). Subcellular targets for photodynamic therapy: implications for initiation of apoptosis and autophagy. J. Natl. Compr. Canc. Netw. 10, S56–S59. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kessel D., Luo Y., Deng Y., Chang C. K. (1997). The role of subcellular localization in initiation of apoptosis by photodynamic therapy. Photochem. Photobiol. 65, 422–426. 10.1111/j.1751-1097.1997.tb08581.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Khrenova M., Topol I., Collins J., Nemukhin A. (2015). Estimating orientation factors in the FRET theory of fluorescent proteins: the TagRFP-KFP pair and beyond. Biophys. J. 108, 126–132. 10.1016/j.bpj.2014.11.1859 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim S., Tachikawa T., Fujitsuka M., Majima T. (2014). Far-red fluorescence probe for monitoring singlet oxygen during photodynamic therapy. J. Am. Chem. Soc. 136, 11707–11715. 10.1021/ja504279r [DOI] [PubMed] [Google Scholar]
- Kobayashi J., Shidara H., Morisawa Y., Kawakami M., Tanahashi Y., Hotta K., et al. (2013). A method for selective ablation of neurons in C. elegans using the phototoxic fluorescent protein, KillerRed. Neurosci. Lett. 548, 261–264. 10.1016/j.neulet.2013.05.053 [DOI] [PubMed] [Google Scholar]
- Krammer B., Verwanger T. (2012). Molecular response to hypericin-induced photodamage. Curr. Med. Chem. 19, 793–798. 10.2174/092986712799034842 [DOI] [PubMed] [Google Scholar]
- Lan L., Nakajima S., Wei L. Z., Sun L. X., Hsieh C. L., Sobol R. W., et al. (2014). Novel method for site-specific induction of oxidative DNA damage reveals differences in recruitment of repair proteins to heterochromatin and euchromatin. Nucleic Acids Res. 42, 2330–2345. 10.1093/nar/gkt1233 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee A., Mathuru A. S., Teh C., Kibat C., Korzh V., Penney T. B., et al. (2010). The habenula prevents helpless behavior in larval zebrafish. Curr. Biol. 20, 2211–2216. 10.1016/j.cub.2010.11.025 [DOI] [PubMed] [Google Scholar]
- Lin J. Y., Sann S. B., Zhou K., Nabavi S., Proulx C. D., Malinow R., et al. (2013). Optogenetic inhibition of synaptic release with chromophore-assisted light inactivation (CALI). Neuron 79, 241–253. 10.1016/j.neuron.2013.05.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu C., Hu M., Ma D., Lei J., Xu J. (2016). Photodynamic inactivation of antibiotic-resistant bacteria and biofilms by hematoporphyrin monomethyl ether. Lasers Med. Sci. 31, 297–304. 10.1007/s10103-015-1859-6 [DOI] [PubMed] [Google Scholar]
- Liu L., Zhang Z. Z., Xing D. (2011). Activation of Bax by lysosomal photodamage induces cell death via mitochondrial apoptotic pathway. Free Radic. Biol. Med. 51, 53–68. 10.1016/j.freeradbiomed.2011.03.042 [DOI] [PubMed] [Google Scholar]
- Lukyanov K. A., Serebrovskaya E. O., Lukyanov S., Chudakov D. M. (2010). Fluorescent proteins as light-inducible photochemical partners. Photochem. Photobiol. Sci. 9, 1301–1306. 10.1039/c0pp00114g [DOI] [PubMed] [Google Scholar]
- Makhijani K., To T. L., Ruiz-González R., Lafaye C., Royant A., Shu X. K. (2017). Precision optogenetic tool for selective single- and multiple-cell ablation in a live animal model system. Cell Chem. Biol. 24, 110–119. 10.1016/j.chembiol.2016.12.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Manoharan G. B., Enkvist E., Kasari M., Viht K., Zenn M., Prinz A., et al. (2015). FRET-based screening assay using small-molecule photoluminescent probes in lysate of cells overexpressing RFP-fused protein kinases. Anal. Biochem. 481, 10–17. 10.1016/j.ab.2015.04.009 [DOI] [PubMed] [Google Scholar]
- Matthews E. K., Cui Z. J. (1989). Photodynamic action of rose bengal on isolated rat pancreatic acini: stimulation of amylase release. FEBS Lett. 256, 29–32. 10.1016/0014-5793(89)81711-9 [DOI] [PubMed] [Google Scholar]
- Matthews E. K., Cui Z. J. (1990a). Photodynamic action of sulphonated aluminium phthalocyanine (SALPC) on AR4-2J cells, a carcinoma cell line of rat exocrine pancreas. Br. J. Cancer 61, 695–701. 10.1038/bjc.1990.157 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Matthews E. K., Cui Z. J. (1990b). Photodynamic action of sulphonated aluminium phthalocyanine (SALPC) on isolated rat pancreatic acini. Biochem. Pharmacol. 39, 1445–1457. 10.1038/bjc.1990.157 [DOI] [PubMed] [Google Scholar]
- Merzlyak E. M., Goedhart J., Shcherbo D., Bulina M. E., Shcheglov A. S., Fradkov A. F., et al. (2007). Bright monomeric red fluorescent protein with an extended fluorescence lifetime. Nat. Methods 4, 555–557. 10.1038/nmeth1062 [DOI] [PubMed] [Google Scholar]
- Miller L. J., Gao F. (2008). Structural basis of cholecystokinin receptor binding and regulation. Pharmacol. Ther. 119, 83–95. 10.1016/j.pharmthera.2008.05.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mironova K. E., Proshkina G. M., Ryabova A. V., Stremovskiy O. A., Lukyanov S. A., Petrov R. V., et al. (2013). Genetically encoded immunophotosensitizer 4D5scFv-miniSOG is a highly selective agent for targeted photokilling of tumor cells in vitro. Theranostics 3, 831–840. 10.7150/thno.6715 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mittra R. A., Singerman L. J. (2002). Recent advances in the management of age-related macular degeneration. Optom. Vis. Sci. 79, 218–224. 10.1097/00006324-200204000-00008 [DOI] [PubMed] [Google Scholar]
- Moan J., Berg K. (1991). The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem. Photobiol. 53, 549–553. 10.1111/j.1751-1097.1991.tb03669.x [DOI] [PubMed] [Google Scholar]
- Munro S., Pelham H. R. (1987). A C-terminal signal prevents secretion of luminal ER proteins. Cell 48, 899–907. 10.1016/0092-8674(87)90086-9 [DOI] [PubMed] [Google Scholar]
- Newman D. K. (2016). Photodynamic therapy: current role in the treatment of chorioretinal conditions. Eye 30, 202–210. 10.1038/eye.2015.251 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Noma K., Jin Y. (2015). Optogenetic mutagenesis in Caenorhabditis elegans. Nat. Commun. 6:8868. 10.1038/ncomms9868 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Norman R. A. (2005). Past and future: porphyria and porphyrins. Skinmed 4, 287–292. 10.1111/j.1540-9740.2005.03706.x [DOI] [PubMed] [Google Scholar]
- Nowis D., Makowski M., Stoklosa T., Legat M., Issat T., Golab J. (2005). Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim. Pol. 52, 339–352. [PubMed] [Google Scholar]
- Oleinick N. L., Evans H. H. (1998). The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat. Res. 150, S146–S156. 10.2307/3579816 [DOI] [PubMed] [Google Scholar]
- Oxford G. S., Pooler J. P., Narahashi T. (1977). Internal and external application of photodynamic sensitizers on squid giant-axons. J. Membr. Biol. 36, 159–173. 10.1007/BF01868149 [DOI] [PubMed] [Google Scholar]
- Peng Q., Farrants G. W., Madslien K., Bommer J. C., Moan J., Danielsen H. E. (1991). Subcellular localization, redistribution and photobleaching of sulfonated aluminum phthalocyanines in a human melanoma cell line. Int. J. Cancer 49, 290–295. 10.1002/ijc.2910490225 [DOI] [PubMed] [Google Scholar]
- Petrova N. V., Luzhin A. V., Serebrovskaya E. O., Ryumina A. P., Velichko A. K., Razin S. V., et al. (2016). Inducing cellular senescence in vitro by using genetically encoded photosensitizers. Aging (Albany. NY) 8, 2449–2462. 10.18632/aging.101065 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pietra F. (2014). Molecular dynamics simulation of dioxygen pathways through mini singlet oxygen generator (miniSOG), a genetically encoded marker and killer protein. Chem. Biodivers. 11, 1883–1891. 10.1002/cbdv.201400125 [DOI] [PubMed] [Google Scholar]
- Pimenta F. M., Jensen R. L., Breitenbach T., Etzerodt M., Ogilby P. R. (2013). Oxygen-dependent photochemistry and photophysics of “‘miniSOG,” a protein-encased flavin. Photochem. Photobiol. 89, 1116–1126. 10.1111/php.12111 [DOI] [PubMed] [Google Scholar]
- Pletnev S., Gurskaya N. G., Pletneva N. V., Lukyanov K. A., Chudakov D. M., Martynov V. I., et al. (2009). Structural basis for phototoxicity of the genetically encoded photosensitizer KillerRed. J. Biol. Chem. 284, 32028–32039. 10.1074/jbc.M109.054973 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pletneva N. V., Pletnev V. Z., Sarkisyan K. S., Gorbachev D. A., Egorov E. S., Mishin A. S., et al. (2015). Crystal structure of phototoxic orange fluorescent proteins with a tryptophan-based chromophore. PLoS ONE 10:e0145740. 10.1371/journal.pone.0145740 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Qi Y. B., Garren E. J., Shu X., Tsien R. Y., Jin Y. (2012). Photo-inducible cell ablation in Caenorhabditis elegans usingthe genetically encoded singlet oxygen-generating protein miniSOG. Proc. Natl. Acad. Sci. U.S.A. 109, 7499–7504. 10.1073/pnas.1204096109 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ragas X., Cooper L. P., White J. H., Nonell S., Flors C. (2011). Quantification of photosensitized singlet oxygen production by a fluorescent protein. Chemphyschem 12, 161–165. 10.1002/cphc.201000919 [DOI] [PubMed] [Google Scholar]
- Rizzuto R., Brini M., Pizzo P., Murgia M., Pozzan T. (1995). Chimeric green fluorescent protein as a tool for visualizing subcellular organelles in living cells. Curr. Biol. 5, 635–642. 10.1016/S0960-9822(95)00128-X [DOI] [PubMed] [Google Scholar]
- Rizzuto R., Nakase H., Darras B., Francke U., Fabrizi G. M., Mengel T., et al. (1989). A gene specifying subunit VIII of human cytochrome c oxidase is localized to chromosome 11 and is expressed in both muscle and non-muscle tissues. J. Biol. Chem. 264, 10595–10600. [PubMed] [Google Scholar]
- Rodríguez-Pulido A., Cortajarena A. L., Torra J., Ruiz-González R., Nonell S., Flors C. (2016). Assessing the potential of photosensitizing flavoproteins as tags for correlative microscopy. Chem. Commun. 52, 8405–8408. 10.1039/C6CC03119F [DOI] [PubMed] [Google Scholar]
- Rosenkranz A. A., Jans D. A., Sobolev A. S. (2000). Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency. Immunol. Cell Biol. 78, 452–464. 10.1046/j.1440-1711.2000.00925.x [DOI] [PubMed] [Google Scholar]
- Roy A., Carpentier P., Bourgeois D., Field M. (2010). Diffusion pathways of oxygen species in the phototoxic fluorescent protein KillerRed. Photochem. Photobiol. Sci. 9, 1342–1350. 10.1039/c0pp00141d [DOI] [PubMed] [Google Scholar]
- Ruiz-González R., White J. H., Agut M., Nonell S., Flors C. (2012). A genetically-encoded photosensitiser demonstrates killing of bacteria by purely endogenous singlet oxygen. Photochem. Photobiol. Sci. 11, 1411–1413. 10.1039/c2pp25126d [DOI] [PubMed] [Google Scholar]
- Ryumina A. P., Serebrovskaya E. O., Shirmanova M. V., Snopova L. B., Kuznetsova M. M., Turchin I. V., et al. (2013). Flavoprotein miniSOG as a genetically encoded photosensitizer for cancer cells. Biochim. Biophys. Acta 1830, 5059–5067. 10.1016/j.bbagen.2013.07.015 [DOI] [PubMed] [Google Scholar]
- Ryumina A. P., Serebrovskaya E. O., Staroverov D. B., Zlobovskaya O. A., Shcheglov A. S., Lukyanov S. A., et al. (2016). Lysosome-associated miniSOG as a photosensitizer for mammalian cells. BioTechniques 61, 92–94. 10.2144/000114445 [DOI] [PubMed] [Google Scholar]
- Sack J. T., Stephanopoulos N., Austin D. C., Francis M. B., Trimmer J. S. (2013). Antibody-guided photoablation of voltage-gated potassium currents. J. Gen. Physiol. 142, 315–324. 10.1085/jgp.201311023 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sarkisyan K. S., Zlobovskaya O. A., Gorbachev D. A., Bozhanova N. G., Sharonov G. V., Staroverov D. B., et al. (2015). KillerOrange, a genetically encoded photosensitizer activated by blue and green light. PLoS ONE 10:e0145287. 10.1371/journal.pone.0145287 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scourides P. A., Bohmer R. M., Kaye A. H., Morstyn G. (1987). Nature of the tumor-localizing components of hematoporphyrin derivative. Cancer Res. 47, 3439–3445. [PubMed] [Google Scholar]
- Serebrovskaya E. O., Edelweiss E. F., Stremovskiy O. A., Lukyanov K. A., Chudakov D. M., Deyev S. M. (2009). Targeting cancer cells by using an antireceptor antibody-photosensitizer fusion protein. Proc. Natl. Acad. Sci. U.S.A. 106, 9221–9225. 10.1073/pnas.0904140106 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Serebrovskaya E. O., Gorodnicheva T. V., Ermakova G. V., Solovieva E. A., Sharonov G. V., Zagaynova E. V., et al. (2011). Light-induced blockage of cell division with a chromatin-targeted phototoxic fluorescent protein. Biochem. J. 435, 65–71. 10.1042/BJ20101217 [DOI] [PubMed] [Google Scholar]
- Serebrovskaya E. O., Ryumina A. P., Boulina M. E., Shirmanova M. V., Zagaynova E. V., Bogdanova E. A., et al. (2014). Phototoxic effects of lysosome-associated genetically encoded photosensitizer KillerRed. J. Biomed. Opt. 19:071403. 10.1117/1.JBO.19.7.071403 [DOI] [PubMed] [Google Scholar]
- Shagin D. A., Barsova E. V., Yanushevich Y. G., Fradkov A. F., Lukyanov K. A., Labas Y. A., et al. (2004). GFP-like proteins as ubiquitous metazoan superfamily: evolution of functional features and structural complexity. Mol. Biol. Evol. 21, 841–850. 10.1093/molbev/msh079 [DOI] [PubMed] [Google Scholar]
- Shaner N. C., Lin M. Z., McKeown M. R., Steinbach P. A., Hazelwood K. L., Davidson M. W., et al. (2008). Improving the photostability of bright monomeric orange and red fluorescent proteins. Nat. Methods 5, 545–551. 10.1038/nmeth.1209 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shibuya T., Tsujimoto Y. (2012). Deleterious effects of mitochondrial ROS generated by KillerRed photodynamic action in human cell lines and C. elegans. J. Photochem. Photobiol. B Biol. 117, 1–12. 10.1016/j.jphotobiol.2012.08.005 [DOI] [PubMed] [Google Scholar]
- Shirmanova M. V., Serebrovskaya E. O., Lukyanov K. A., Snopova L. B., Sirotkina M. A., Prodanetz N. N., et al. (2013). Phototoxic effects of fluorescent protein KillerRed on tumor cells in mice. J. Biophotonics 6, 283–290. 10.1002/jbio.201200056 [DOI] [PubMed] [Google Scholar]
- Shirmanova M., Yuzhakova D., Snopova L., Perelman G., Serebrovskaya E., Lukyanov K., et al. (2015). Towards PDT with genetically encoded photosensitizer KillerRed: a comparison of continuous and pulsed laser regimens in an animal tumor model. PLoS ONE 10:e0144617. 10.1371/journal.pone.0144617 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shkryl V. M., Maxwell J. T., Blatter L. A. (2012). A novel method for spatially complex diffraction-limited photoactivation and photobleaching in living cells. J. Physiol. 590, 1093–1100. 10.1113/jphysiol.2011.223446 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shu X., Lev-Ram V., Deerinck T. J., Qi Y., Ramko E. B., Davidson M. W., et al. (2011). A genetically encoded tag for correlated light and electron microscopy of intact cells, tissues, and organisms. PLoS Biol. 9:e1001041. 10.1371/journal.pbio.1001041 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Skene J. H., Virág I. (1989). Posttranslational membrane attachment and dynamic fatty acylation of a neuronal growth cone protein, GAP-43. J. Cell Biol. 108, 613–624. 10.1083/jcb.108.2.613 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Subach O. M., Malashkevich V. N., Zencheck W. D., Morozova K. S., Piatkevich K. D., Almo S. C., et al. (2010). Structural characterization of acylimine-containing blue and redchromophores in mTagBFP and TagRFP fluorescent proteins. Chem. Biol. 17, 333–341. 10.1016/j.chembiol.2010.03.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sun L., Tan R., Xu J., LaFace J., Gao Y., Xiao Y., et al. (2015). Targeted DNA damage at individual telomeres disrupts their integrity and triggers cell death. Nucleic Acids Res. 43, 6334–6347. 10.1093/nar/gkv598 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Szeimies R. M., Stockfleth E., Popp G., Borrosch F., Brüning H., Dominicus R., et al. (2010). Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data. Br. J. Dermatol. 162, 410–414. 10.1111/j.1365-2133.2009.09377.x [DOI] [PubMed] [Google Scholar]
- Tabuchi N., Akasaki K., Tsuji H. (2000). Two acidic amino acid residues, Asp(470) and Glu(471), contained in the carboxyl cytoplasmic tail of a major lysosomal membrane protein, LGP85 / LIMP II, are important for its accumulation in secondary lysosomes. Biochem. Biophys. Res. Commun. 270, 557–563. 10.1006/bbrc.2000.2448 [DOI] [PubMed] [Google Scholar]
- Takemoto K., Matsuda T., Sakai N., Fu D., Noda M., Uchiyama S., et al. (2013). SuperNova, a monomeric photosensitizing fluorescent protein for chromophore-assisted light inactivation. Sci. Rep. 3:2629. 10.1038/srep02629 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tarr M., Valenzeno D. P. (1991). Modification of cardiac ionic currents by photosensitiser-generated reactive oxygen. J. Mol. Cell. Cardiol. 23, 639–649. 10.1016/0022-2828(91)90055-Q [DOI] [PubMed] [Google Scholar]
- Teh C., Chudakov D. M., Poon K. L., Mamedov I. Z., Sek J. Y., Shidlovsky K., et al. (2010). Optogenetic in vivo cell manipulation in KillerRed-expressing zebrafish transgenics. BMC Dev. Biol. 10:110. 10.1186/1471-213X-10-110 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Theodossiou T. A., Noronha-Dutra A., Hothersall J. S. (2006). Mitochondria are a primary target of hypericin phototoxicity: synergy of intracellular calcium mobilisation in cell killing. Int. J. Biochem. Cell Biol. 38, 1946–1956. 10.1016/j.biocel.2006.05.009 [DOI] [PubMed] [Google Scholar]
- Torra J., Burgos-Caminal A., Endres S., Wingen M., Drepper T., Gensch T. (2015). Singlet oxygen photosensitisation by the fluorescent protein Pp2FbFP L30M, a novel derivative of Pseudomonas putida flavin-binding Pp2FbFP. Photochem. Photobiol. Sci. 14, 280–287. 10.1039/c4pp00338a [DOI] [PubMed] [Google Scholar]
- Usuda J., Azizuddin K., Chiu S. M., Oleinick N. L. (2003). Association between the photodynamic loss of Bcl-2 and the sensitivity to apoptosis caused by phthalocyanine photodynamic therapy. Photochem. Photobiol. 78, 1–8. 10.1562/0031-8655(2003)0780001ABTPLO2.0.CO2 [DOI] [PubMed] [Google Scholar]
- Usuda J., Chiu S. M., Azizuddin K., Xue L. Y., Lam M., Nieminen A. L., et al. (2002). Promotion of photodynamic therapy-induced apoptosis by the mitochondrial protein Smac/DIABLO: dependence on Bax. Photochem. Photobiol. 76, 217–223. 10.1562/0031-8655(2002)0760217POPTIA2.0.CO2 [DOI] [PubMed] [Google Scholar]
- Valenzeno D. P., Tarr M. (1997). GH3 cells, ionic currents and cell killing: photomodification sensitized by Rose Bengal. Photochem. Photobiol. 68, 519–526. 10.1111/j.1751-1097.1998.tb02508.x [DOI] [PubMed] [Google Scholar]
- Vegh R. B., Solntsev K. M., Kuimova M. K., Cho S., Liang Y., Loo B. L., et al. (2011). Reactive oxygen species in photochemistry of the red fluorescent protein “KillerRed”. Chem. Commun. 47, 4887–4889. 10.1039/c0cc05713d [DOI] [PubMed] [Google Scholar]
- Waldeck W., Mueller G., Glatting K. H., Hotz-Wagenblatt A., Diessl N., Chotewutmonti S., et al. (2013). Spatial localization of genes determined by intranuclear DNA fragmentation with the fusion proteins lamin KRED and histone KRED und visible light. Intl J Med Sci 10, 1136–1148. 10.7150/ijms.6121 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Waldeck W., Mueller G., Wiessler M., Tóth K., Braun K. (2011). Positioning effects of KillerRed inside of cells correlate with DNA strand breaks after activation with visible Light. Int. J. Med. Sci. 8, 97–105. 10.7150/ijms.8.97 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wan Q. L., Liu L., Xing D., Chen Q. (2008). Bid is required in NPe6-PDT-induced apoptosis. Photochem. Photobiol. 84, 250–257. 10.1111/j.1751-1097.2007.00248.x [DOI] [PubMed] [Google Scholar]
- Wang N., Liu Y., Xie M. X., Cui Z. J. (2003). Changes in plasma membrane protein structure after photodynamic action in freshly isolated rat pancreatic acini. An FTIR study. J. Photochem. Photobiol. B Biol. 71, 27–34. 10.1016/j.jphotobiol.2003.07.001 [DOI] [PubMed] [Google Scholar]
- Westberg M., Bregnhoj M., Banerjee C., Blazquez-Castro A., Breitenbach T., Ogilby P. R. (2016). Exerting better control and specificity with singlet oxygen experiments in live mammalian cells. Methods 109, 81–91. 10.1016/j.ymeth.2016.07.001 [DOI] [PubMed] [Google Scholar]
- Westberg M., Holmegaard L., Pimenta F. M., Etzerodt M., Ogilby P. R. (2015). Rational design ofan efficient, genetically encodable, proteinencased singlet oxygen photosensitizer. J. Am. Chem. Soc. 137, 1632–1642. 10.1021/ja511940j [DOI] [PubMed] [Google Scholar]
- Williams D. C., Bejjani R. E., Ramirez P. M., Coakley S., Kim S. A., Lee H., et al. (2013). Rapid and permanent neuronal inactivation in vivo via subcellular generation of reactive oxygen with the use of KillerRed. Cell Rep. 5, 553–563. 10.1016/j.celrep.2013.09.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wingen M., Potzkei J., Endres S., Casini G., Rupprecht C., Fahlke C., et al. (2014). The photophysics of LOV-based fluorescent proteins–new tools for cell biology. Photochem. Photobiol. Sci. 13, 875–883. 10.1039/c3pp50414j [DOI] [PubMed] [Google Scholar]
- Wojtovich A. P., Wei A. Y., Sherman T. A., Foster T. H., Nehrke K. (2016). Chromophore-assisted light inactivation of mitochondrial electron transport chain complex II in Caenorhabditis elegans. Sci. Rep. 6:29695. 10.1038/srep29695 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xu S., Chisholm A. D. (2016). Highly efficient optogenetic cell ablation in C. elegans using membrane-targeted miniSOG. Sci. Rep. 6, 21271–21283. 10.1038/srep21271 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Xue L. Y., Chiu S. M., Oleinick N. L. (2001). Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4. Oncogene 20, 3420–3427. 10.1038/sj.onc.1204441 [DOI] [PubMed] [Google Scholar]
- Yang J. Y., Yang W. Y. (2011). Spatiotemporally controlled initiation of Parkin-mediated mitophagy within single cells. Autophagy 7, 1230–1238. 10.4161/auto.7.10.16626 [DOI] [PubMed] [Google Scholar]
- Yu N., Smagghe G. (2014). CCK(-like) and receptors: structure and phylogeny in a comparative perspective. Gen. Comp. Endocrinol. 209, 74–81. 10.1016/j.ygcen.2014.05.003 [DOI] [PubMed] [Google Scholar]
- Zhou K. M., Stawicki T. M., Goncharov A., Jin Y. (2013). Position of UNC-13 in the active zone regulates synaptic vesicle release probability and release kinetics. Elife 2:e01180. 10.7554/elife.01180 [DOI] [PMC free article] [PubMed] [Google Scholar]